Find information and relevant documents on past and upcoming investor-related events, including the Annual Shareholders Meeting and broker conferences.

Investor Events and Presentations | Takeda Pharmaceuticals

Investor

# Investor Events



Divider Section Redesign

## Contents


### TD Cowen 45th Annual Health Care Conference

(2:30-3:10pm EST on March 3, 2025)    <br>

*  [Takeda Session Link (Audio Only)](http://wsw.com/webcast/cowen177/tak/1850592)

***

### Quarterly Results - Quarter 4 FY2024

(May 8, 2025)

***

### Quarterly Results - Quarter 1 FY2025

(July 30, 2025)

***

Upcoming Events

### Quarterly Results - Quarter 3 FY2024

(January 30, 2025)

*   [Read more](/investors/financial-results/quarterly-results/)

***


### 43rd Annual J.P. Morgan Healthcare Conference

(1:30 – 2:10pm PST on January 14, 2025) 

*  [Presentation](http://assets-dam.ducciofiorini.com/image/upload/Global/Investor/events/2025/documents/JPMHC_2025_presentation.pdf)

***
	
### R&D Day: Focus on Late-Stage Pipeline and Market Opportunity

(6:30pm ~ EST on December 12, 2024)<br>

*   [Webcast](http://www.irwebcasting.com/20241213/3/)

*   [Presentation](http://assets-dam.ducciofiorini.com/image/upload/Global/Investor/events/2024/RD_Presentation_2024_EN.pdf)

*   [Transcript](http://assets-dam.ducciofiorini.com/image/upload/Global/Investor/events/2024/Takeda_RD_Day_12_2024_Transcript_vF.pdf)

***

### Quarterly Results - Quarter 2 FY2024

(October 31, 2024)

*   [Read more](/investors/financial-results/quarterly-results/)

***

### Quarterly Results - Quarter 1 FY2024

(July 31, 2024)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results/)

***

### TAK-861 Investor Call on Phase 2b Narcolepsy Type 1 Data

(7:30pm- 8:30pm CDT, 8:30pm - 9:30pm EDT on June 3, 2024)

*   [Webcast](http://www.irwebcasting.com/20240604/4/index.html)

*   [Presentation](http://assets-dam.ducciofiorini.com/image/upload/v1717400991/Global/Investor/events/2024/tak-861-investor-call-en.pdf)

***

### Quarterly Results - Quarter 4 FY2023

(May 9, 2024)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2023/)

***


FY2024 Past Events

<div id="earnings-announcement-meetings--ir-events--broker-conferences">## Earnings Announcement Meetings / IR Events / Broker Conferences

#### Cowen 44<sup>th</sup> Health Care Conference

(9:50am – 10:20am EST on March 6, 2024)

*   This event was closed.

***

#### Quarterly Results - Quarter 3 FY2023

(February 1, 2024)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2023/)

***

#### 42nd Annual J.P. Morgan Healthcare Conference

(5:15pm – 5:55pm PST on January 8, 2024)

*   This event was closed.

***

#### Plasma-Derived Therapies Investor Event

(6:00 – 7:00pm EST on December 5, 2023)

*   [Webcast](http://www.irwebcasting.com/20231206/3/index.html)
*   [Presentation](http://assets-dam.ducciofiorini.com/image/upload/v1701756390/Global/Investor/events/2023/PDT_Presentation_2023_EN.pdf)

***

#### Jefferies London Healthcare Conference

(4:00 – 4:25am EST on November 14, 2023)

(9:00 – 9:25am GMT on November 14, 2023)

*   This event was closed.

***

#### Quarterly Results - Quarter 2 FY2023

(October 26, 2023)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2023/)

***

#### Morgan Stanley Healthcare Conference

(3:35 – 4:05pm EDT on September 11, 2023)

*   This event was closed.

***

#### Quarterly Results - Quarter 1 FY2023

(July 27, 2023)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2023/)

***

#### Quarterly Results - Quarter 4 FY2022

(May 11, 2023)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2022/)

***


FY2023 (April 2023-March 2024)

#### TAK-279 (TYK2 inhibitor) Investor Call on Phase 2b Psoriasis Data

(March 18, 2023)

*   [Webcast](http://www.irwebcasting.com/20230319/2/index.html)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1679175992/siteassets/system/investors/investor--events/TAK-279%20Investor%20Call_EN.pdf)

***

#### QDENGA Investor call

(March 15, 2023)

*   [Webcast](http://www.irwebcasting.com/20230316/2/index.html)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1679624806/siteassets/system/investors/investor--events/Qdenga%20Presentation_EN.pdf)

***

#### Cowen 43rd Health Care Conference

(March 6, 2023)

*   This event was closed.

***

#### Quarterly Results - Quarter 3 FY2022

(February 2, 2023)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2022/)

***

#### 41st Annual J.P. Morgan Healthcare Conference

(January 9, 2023)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1675192363/legacy-dotcom/siteassets/system/investors/investor--events/jpmhc23_presentation.pdf)

***

#### Conference call regarding acquisition of NDI-034858 From Nimbus Therapeutics

(December 13, 2022)

*   [Presentation](http://jvgmtt.ducciofiorini.com/4af01e/siteassets/system/investors/investor--events/takeda-ir-call_en.pdf)

*   [Webcast](http://www.irwebcasting.com/20221214/3/index.html)

***

#### Jefferies London Healthcare Conference

(November 15, 2022)

*   This event was closed.

***

#### Quarterly Results - Quarter 2 FY2022

(October 27, 2022)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2022/)

***

#### Seminar: Investors and Analysts on Lysosomal Storage Diseases (LSD)

(October 4, 2022)

*   [Presentation](http://jvgmtt.ducciofiorini.com/4a7c83/siteassets/system/investors/investor--events/en_lsd-ir-disease-seminar.pdf)

*   [Webcast](http://www.irwebcasting.com/20221004/2/index.html)

***

#### Morgan Stanley Healthcare Conference

(September 12, 2022)

*   This event was closed.

***

#### Quarterly Results - Quarter 1 FY2022

(July 28, 2022)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2022/)

***

#### Jefferies Healthcare Conference

(June 9, 2022)

*   This event was closed.

***

#### Quarterly Results - Quarter 4 FY2021

(May 11, 2022)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2021/)


FY2022 (April 2022-March 2023)

### Cowen 42<sup>nd</sup> Health Care Conference

(2:50pm – 3:20pm EST on March 8, 2022)

*   This event was closed.

***

### Seminar: Investors and Analysts on Short Bowel Syndrome (SBS) and Complex Crohn’s Perianal Fistulas (CPF)

(1:00pm JST on February 24, 2022)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1675192360/legacy-dotcom/siteassets/system/investors/investor--events/en_ir-disease-seminar_gi.pdf)

*   [Webcast](http://www.irwebcasting.com/20220224/2/index.html)

***

### Quarterly Results - Quarter 3 FY2021

(Held on February 3, 2022)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2021/)

***

### 40<sup>th </sup>Annual J.P. Morgan Healthcare Conference

(4:30pm – 5:10pm EST on January 10, 2022)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1675192362/legacy-dotcom/siteassets/system/investors/investor--events/jpmhc-presentation_2022.pdf)

***

### Takeda Management Call

(6:00pm – 7:00pm EST on January 10, 2022)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1675192360/legacy-dotcom/siteassets/system/investors/investor--events/en_takeda-mgmt-call_jan-11.pdf)

***

### Plasma-Derived Therapies Investor Event

(5:30pm – 7:30pm EST on November 17, 2021)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1662727524/legacy-dotcom/siteassets/system/investors/investor--events/IRDayPresentation_EN.pdf)

***

### Quarterly Results - Quarter 2 FY2021

(Held on October 28, 2021)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2021/)

***

### Quarterly Results - Quarter 1 FY2021

(Held on July 30, 2021)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2021/)

***

### Finance Investor Day

(7:00pm – 9:00pm EDT on July 12, 2021)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1675192361/legacy-dotcom/siteassets/system/investors/investor--events/finance-investor-day_en.pdf)

***

### Oncology Strategic Update Call

(6:30pm – 7:45pm EDT on June 8, 2021)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1675192360/legacy-dotcom/siteassets/system/investors/investor--events/asco-2021-ir-event_en.pdf)

***

### 2021 Biopharma CEO Investor Forum

(8:00am – 8:50am EDT on June 7, 2021)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1662727530/legacy-dotcom/siteassets/system/investors/investor--events/Takeda_CECP_CEO.pdf)

***

### Wave 1 Pipeline Market Opportunity Call Part 2

(8:00am – 10:30am EDT on April 6, 2021)  

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1662727532/legacy-dotcom/siteassets/system/investors/investor--events/Wave1MarketEventPart2_EN.pdf)

*   [R\&D Pipeline Factsheet](http://assets-dam.ducciofiorini.com/raw/upload/v1662727534/legacy-dotcom/siteassets/system/what-we-do/research-and-development-rd-in-takeda/our-pipeline/PipelineFactsheet_Apr_2021.pdf)

***

### Quarterly Results - Quarter 4 FY2020

(Held on May 11, 2021)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2020/)

FY2021 (April 2021-March 2022)

### Growth and Emerging Markets Strategic Update Call

(6:30am-8:15am EST on March 11, 2021) 

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1662727532/legacy-dotcom/siteassets/system/investors/investor--events/GEM-IR-Day-Presentation.pdf)

***

### Seminar: Investors and Analysts on Takeda’s Japan Oncology Business and its oncology products and disease in Japan

(1:00pm-2:45pm JST on February 25, 2021)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1675192359/legacy-dotcom/siteassets/system/investors/investor--events/20210225_japan-_oncology-event_en.pdf)

***

### Quarterly Results - Quarter 3 FY2020

(Held on February 4, 2021)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2020/)

***

### World Conference on Lung Cancer (WCLC) Investor Event

(5:00pm-6:00pm EST on January 29, 2021)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1662727535/legacy-dotcom/siteassets/system/investors/investor--events/WCLC-2021-IR-Event.pdf)

***

### 39<sup>th </sup>Annual J.P. Morgan Healthcare Conference

(5:20pm-6:00pm EST on January 11, 2021)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1662727538/legacy-dotcom/siteassets/system/investors/investor--events/JPMHC2021.pdf)

***

### Wave 1 Pipeline Market Opportunity Call

(5:00pm-7:15pm EST on December 8, 2020)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1662727539/legacy-dotcom/siteassets/system/investors/investor--events/Wave1presentation_en.pdf)

***

### Quarterly Results - Quarter 2 FY2020

(Held on October 29, 2020)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2020/)

***

### Seminar: Investors and Analysts on Inflammatory Bowel Disease

(1:00pm JST on September 2, 2020)

*   [Presentation](http://jvgmtt.ducciofiorini.com/4ab563/siteassets/system/investors/report/quarterlyannouncements/fy2020/20200902_ibd_en.pdf)

***

### Quarterly Results - Quarter 1 FY2020

(Held on July 31, 2020)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2020/)

***

### Seminar: Investors and Analysts on Hereditary Angioedema (HAE)

(1:00pm JST on June 30, 2020) 

*   [Presentation](http://jvgmtt.ducciofiorini.com/4ab54d/siteassets/system/investors/report/quarterlyannouncements/fy2020/20200630_p01_en.pdf)

***

### Oncology Focused Investor Call

(8:00am EDT / 9:00pm JST on June 8, 2020)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1675192591/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2020/june-8-onc-investor-event-presentation-06.02.20-final.pdf)

***

### Quarterly Results - Quarter 4 FY2019

(Held on May 13, 2020)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2019/)

FY2020 (April 2020-March 2021)

### Quarterly Results - Quarter 3 FY2019

(Held on February 4, 2020)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2019/)

***

### 38<sup>th </sup>Annual J.P. Morgan Healthcare Conference

(4:00pm-4:55pm PST on January 14, 2020)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1662727548/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/JPMHC_2020.pdf)

***

### R\&D Day and Plasma-Derived Therapies Day in Tokyo

(11:00am-5:00pm JST on November 21, 2019)

#### Plasma-Derived Therapies

*   Plasma-Derived Therapies Overview: Julie Kim, President, Plasma-Derived Therapies Business Unit

*   Plasma-Derived Therapies R\&D: Christopher Morabito, Head, R\&D, Plasma-Derived Therapies

*   [Click to Download](http://assets-dam.ducciofiorini.com/image/upload/v1729283799/Global/Investor/events/2019/pdt_day_tokyo.pdf) 

#### R\&D Day

*   [Click to Download the slides](http://assets-dam.ducciofiorini.com/raw/upload/v1675192582/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_tokyo-rd-day_all-slides_final_20191121.pdf)

*   [Takeda: A Global Values-Based, R\&D-Driven Biopharmaceutical Leader: ](http://assets-dam.ducciofiorini.com/raw/upload/v1675192577/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_0---takeda_rdday_intro_final.pdf)Christophe Weber, President & CEO

*   [Translating Science into Highly Innovative, Life-changing Medicines: ](http://assets-dam.ducciofiorini.com/raw/upload/v1675192576/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_1---andy-rd-day_final.pdf)Andy Plump, President, R\&D

*   [Oncology and Cell Therapies with Spotlight on CAR-NK: ](http://assets-dam.ducciofiorini.com/raw/upload/v1675192576/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_2---io-rd-day_final.pdf)Chris Arendt, Head, Oncology Drug Discovery Unit

*   [Spotlight on Oncology Opportunities TAK-788: ](http://assets-dam.ducciofiorini.com/raw/upload/v1675192575/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_3---tak-788-rd-day_final.pdf)Rachael Brake, Global Program Leader, Oncology

*   [Spotlight on Oncology Opportunities Pevonedistat: ](http://assets-dam.ducciofiorini.com/raw/upload/v1675192577/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_4---tak-924-rd-day_final.pdf)Phil Rowlands, Head, Oncology Therapeutic Area Unit

*   [Rare Diseases & Gene Therapy: ](http://assets-dam.ducciofiorini.com/raw/upload/v1675192577/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_5---rare-disease-rd-day_final.pdf)Dan Curran, Head, Rare Disease Therapeutic Area Unit

*   [Spotlight on Orexin2R agonists: ](http://assets-dam.ducciofiorini.com/raw/upload/v1675192577/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_6---ox2r-rd-day_final.pdf)Deborah Hartman, Global Program Leader, Neuroscience

*   [Therapeutic Area Focus in GI with Spotlight on Celiac Disease: ](http://assets-dam.ducciofiorini.com/raw/upload/v1675192578/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_7---gi-rd-days_final.pdf)Asit Parikh, Head, GI Therapeutic Area Unit

*   [Takeda R\&D Pipeline Narrative](http://assets-dam.ducciofiorini.com/raw/upload/v1675192589/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/takeda-rd-pipeline-narrative_20191114.pdf)

***

### Plasma-Derived Therapies Day in Covington, Georgia

(11:15am-3:45pm EST on November 15, 2019)

*   [All slides](http://assets-dam.ducciofiorini.com/raw/upload/v1662727582/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/PDT_20191115.pdf)

*   Plasma-Derived Therapies Overview: Julie Kim, President, Plasma-Derived Therapies Business Unit

*   Plasma-Derived Therapies R\&D: Christopher Morabito, Head, R\&D, Plasma-Derived Therapies

*   Covington Site Introduction: Carlos Soto, Covington Site Head

***

### R\&D Day in New York

(12:30pm-4:00pm EST on November 14, 2019)

*   [All slides](http://assets-dam.ducciofiorini.com/raw/upload/v1675192578/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/all-slides_20191114_vf.pdf)

*   Welcome and Opening Remarks: Sheelagh Cawley-Knopf, Head, R\&D Global Portfolio Strategy

*   [Takeda: A Global Values-Based, R\&D-Driven Biopharmaceutical Leader](http://assets-dam.ducciofiorini.com/raw/upload/v1675192572/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/0---christophe--slide-20191114_vf.pdf): Christophe Weber, President & CEO

*   [Translating Science into Highly Innovative, Life-changing Medicines](http://assets-dam.ducciofiorini.com/raw/upload/v1662727595/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/1_Andy_20191114.pdf): Andy Plump, President, R\&D

*   [Oncology and Cell Therapies with Spotlight on CAR-NK](http://assets-dam.ducciofiorini.com/raw/upload/v1662727596/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/2_IO_20191114.pdf): Chris Arendt, Head, Oncology Drug Discovery Unit

*   [Spotlight on Oncology Opportunities TAK-788](http://assets-dam.ducciofiorini.com/raw/upload/v1662727598/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/3_TAK788_20191114.pdf): Rachael Brake, Global Program Leader, Oncology

*   [Spotlight on Oncology Opportunities Pevonedistat](http://assets-dam.ducciofiorini.com/raw/upload/v1662727599/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/4_TAK924_20191114.pdf): Phil Rowlands, Head, Oncology Therapeutic Area Unit

*   [Rare Diseases & Gene Therapy](http://assets-dam.ducciofiorini.com/raw/upload/v1675192574/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/5_rare-disease_20191114_2.pdf): Dan Curran, Head, Rare Disease Therapeutic Area Unit

*   [Spotlight on Orexin2R agonists](http://assets-dam.ducciofiorini.com/raw/upload/v1662727602/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/6_OX2R_20191114.pdf): Deborah Hartman, Global Program Leader, Neuroscience

*   [Therapeutic Area Focus in GI with Spotlight on Celiac Disease](http://assets-dam.ducciofiorini.com/raw/upload/v1662727604/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/7_GI_20191114.pdf): Asit Parikh, Head, GI Therapeutic Area Unit

*   [Takeda R\&D Pipeline Narrative](http://assets-dam.ducciofiorini.com/raw/upload/v1675192589/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/takeda-rd-pipeline-narrative_20191114.pdf)

***

### Quarterly Results - Quarter 2 FY2019

(Held on October 31, 2019)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2019/)

***

### IR meeting with analysts and investors with Julie Kim, President of Takeda's Plasma-Derived Therapies Business Unit

(Held on October 10, 2019)

*   This event was closed.

***

### Morgan Stanley Healthcare Conference

(Held on September 10, 2019 ET)

*   This event was closed.

***

### Quarterly Results - Quarter 1 FY2019

(Held on July 31, 2019)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2019/)

***

### IR Seminar “Plasma-Derived Therapies Business”

(Held on July 12, 2019)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1675192570/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/20190712-ir-presentation-on-pdt_final_e.pdf)

***

### Quarterly Results - Quarter 4 FY2018

(Held on May 14, 2019)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2018/)

FY2019 (April 2019-March 2020)

### Quarterly Results - Quarter 3 FY2018

(Held on February 1, 2019)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2018/)

***

### 37<sup>th </sup>Annual J.P. Morgan Healthcare Conference

(Held on January 8, 2019 PST)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1662727541/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/fy2018-q2-announcements/JPMHC2019-E.pdf)

***

### Meeting regarding Acquisition of Shire plc by Takeda

(Held on January 7, 2019) 

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1675192566/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/fy2018-q2-announcements/shire-deal-close-announcement_en.pdf): A Global, Values-based, R&D-driven Biopharmaceutical Leader

*   [More details on Takeda's offer to acquire Shire Plc.](http://jvgmtt.ducciofiorini.com/investors/offer-for-shire/)

***

### Quarterly Results - Quarter 2 FY2018

(Held on October 31, 2018)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2018/)

***

### Takeda’s R&D Investor Day (Boston)

(October 11, 2018)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1662727546/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/0_FULL_DECK_Boston_E.pdf): Delivering on our R&D vision

*   Andy Plump, Chief Medical and Scientific Officer

    *   [Oncology](http://assets-dam.ducciofiorini.com/raw/upload/v1662727548/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/1_Oncology_Boston_E.pdf)

    *   [Gastroenterology](http://assets-dam.ducciofiorini.com/raw/upload/v1662727549/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/2_GI_DECK_Boston_E.pdf)

    *   [Neuroscience](http://assets-dam.ducciofiorini.com/raw/upload/v1662727551/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/3_NS_DECK_Boston_E.pdf)

    *   [Vaccines](http://assets-dam.ducciofiorini.com/raw/upload/v1662727552/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/4_VBU_DECK_Boston_E.pdf)

***

### Takeda’s R&D Investor Day (Tokyo)

(September 27, 2018)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1662727554/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/0_FULLDECK_E_rd_day.pdf): Delivering on our R&D vision

*   Andy Plump, Chief Medical and Scientific Officer

    *   [Oncology](http://assets-dam.ducciofiorini.com/raw/upload/v1662727555/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/1_ONCOLOGY_E.pdf)

    *   [Gastroenterology](http://assets-dam.ducciofiorini.com/raw/upload/v1662727557/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/2_GI_E.pdf)

    *   [Neuroscience](http://assets-dam.ducciofiorini.com/raw/upload/v1662727558/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/3_NS_E.pdf)

    *   [Vaccines](http://assets-dam.ducciofiorini.com/raw/upload/v1662727559/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/4_VACCINE_E.pdf)

    *   [Shonan iPark](http://assets-dam.ducciofiorini.com/raw/upload/v1662727560/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/5_IPARK_E.pdf)

***

### Quarterly Results - Quarter 1 FY2018

(Held on July 31, 2018)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2018/)

***

### Quarterly Results - Quarter 4 FY2017

(Held on May 14, 2018)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2017/)

***

### Conference Call Regarding Proposed Acquisition of Shire plc by Takeda

(Held on May 8/9, 2018)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1675192569/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/takeda-to-acquire-shire-accelerating-takeda_s-transformation-to-deliver-more-for-patients.pdf): Takeda to Acquire Shire-Accelerating Takeda’s Transformation to Deliver More for Patients



FY2018 (April 2018-March 2019)

### Quarterly Results - Quarter 3 FY2017

(Held on February 1, 2018)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2017/)

***

### 36<sup>th </sup>Annual J.P. Morgan Healthcare Conference

(Held on January 8, 2018 PST)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1662727540/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2017/36th-annual-j.p.-morgan-healthcare-conference-held-on-january-8-2018-pst/qr2017_q3_p01_en.pdf)

***

### Jefferies 2017 Global Healthcare Conference

(Presented November 16, 2017, 10:00 GMT)

*   This event was closed.

***

### Quarterly Results - Quarter 2 FY2017

(Held on November 1, 2017)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2017/)

***

### Quarterly Results - Quarter 1 FY2017

(Held on July 28, 2017)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2017/)

***

### UBS Global Healthcare Conference

(Released on May 23, 2017, 9:30 EDT)

*   This event was closed.

***

### Quarterly Results - Quarter 4 FY2016

(Held on May 10, 2017)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2016/)

FY2017 (April 2017-March 2018)

### Quarterly Results - Quarter 3 FY2016

(Held on February 1, 2017)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2016/)

***

### Conference Call on the Acquisition of ARIAD Pharmaceuticals

(Released on January 10, 2017)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1675192549/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2016/conference-call-on-the-acquisition-of-ariad-pharmaceuticals-released-on-january-10-2017/takeda-to-acquire-ariad-pharmaceuticals.pdf)

***

### 35<sup>th</sup>Annual J.P. Morgan Healthcare Conference

(Held on January 9, 2017)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1675192549/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2016/35thannual-j.p.-morgan-healthcare-conference-held-on-january-9-2017/j.p.-morgan-healthcare-conference-presentation.pdf)

***

### Quarterly Results - Quarter 2 FY2016

(Held on October 28, 2016)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2016/)

***

### Quarterly Results - Quarter 1 FY2016

(Held on July 29, 2016)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2016/)

***

### Takeda IR Day

(Held on June 9, 2016)

1.  [Takeda Oncology: ](http://assets-dam.ducciofiorini.com/raw/upload/v1675192554/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2016/takeda-ir-day-held-on-june-9-2016/1.-takeda-oncology.pdf)Christophe Bianchi, President, Global Oncology Business Unit

2.  [Focused World Class R&D New approaches to innovation: ](http://assets-dam.ducciofiorini.com/raw/upload/v1675192555/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2016/takeda-ir-day-held-on-june-9-2016/2.-focused-world-class-r_d.pdf)Andrew Plump, Chief Medical & Scientific Officer

***

### Quarterly Results - Quarter 4 FY2015

(Held on May 10, 2016)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2015/)

FY2016 (April 2016-March 2017)

### Quarterly Results - Quarter 3 FY2015

(Held on February 3, 2016)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2015/)

***

### 34th Annual J.P. Morgan Healthcare Conference

(Held on January 12, 2016)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1662727538/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2015/34th-annual-j.p.-morgan-healthcare-conference-held-on-january-12-2016/qr2015_q3_p01_en.pdf)

***

### Quarterly Results - Quarter 2 FY2015

(Held on October 30, 2015)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2015/)

***

### Quarterly Results - Quarter 1 FY2015

(Held on July 30, 2015)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2015/)

***

### Quarterly Results - Quarter 4 FY2014

(Held on May 15, 2015)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2014/)

FY2015 (April 2015-March 2016)

### Takeda IR Event: A Global Leader in Gastroenterology

(Held on March 9, 2015)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1662727534/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2014/takeda-ir-event--a-global-leader-in-gastroenterology-held-on-march-9-2015/qr2014_q3_p_en.pdf)

***

### Quarterly Results - Quarter 3 FY2014

(Held on February 5, 2015)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2014/)

***

### 33<sup>rd</sup> Annual J.P. Morgan Healthcare Conference

(Held on January 13, 2015)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1662727535/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2014/33rd-annual-j.p.-morgan-healthcare-conference-held-on-january-13-2015/qr2014_q3_e01_en.pdf)

***

### Quarterly Results - Quarter 2 FY2014

(Held on October 30, 2014)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2014/)

***

### Quarterly Results - Quarter 1 FY2014

(Held on August 1, 2014)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2014/)

***

### Quarterly Results - Quarter 4 FY2013

(Held on May 8, 2014)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2013/)

FY2014 (April 2014-March 2015)

### Quarterly Results - Quarter 3 FY2013

(Held on February 5, 2014)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2013/)

***

### 32<sup>nd</sup> Annual J.P. Morgan Healthcare Conference

(Held on January 13, 2014)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1675192534/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2013/32nd-annual-j.p.-morgan-healthcare-conference-held-on-january-13-2014/j.p.-morgan-healthcare-conference-presentation.pdf)

***

### Quarterly Results - Quarter 2 FY2013

(Held on October 31, 2013)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2013/)

***

### Quarterly Results - Quarter 1 FY2013

(Held on July 31, 2013)

*   [Read more](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results-2013/)

FY2013 (April 2013-March 2014)

## Event Archive



### 148th Ordinary General Meeting of Shareholders (June 26, 2024)

*   [Notice of Convocation of the 148th Ordinary General Meeting of Shareholders](http://assets-dam.ducciofiorini.com/image/upload/v1716784771/Global/Investor/events/shareholders-meetings/2024/sm_148_01_en.pdf)

*   [Other items which are provided electronically](http://assets-dam.ducciofiorini.com/image/upload/v1716771549/Global/Investor/events/shareholders-meetings/2024/sm_148_02_en.pdf)

*   [Message from Christophe Weber, President & CEO](http://jvgmtt.ducciofiorini.com/investors/events/shareholder-letter-2024)

*   [Takeda’s executive compensation overview](http://assets-dam.ducciofiorini.com/image/upload/v1716782703/Global/Investor/events/shareholders-meetings/2024/sm_148_04_en.pdf)

*   [FY2023 Q4 Financial Results](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results/)

*   [Statement from Masami Iijima, Chair of the Board of Directors Meeting of Takeda, in Response to Institutional Shareholder Services Inc.’s Voting Recommendations Ahead of the 148th Ordinary General Meeting of Shareholders](http://assets-dam.ducciofiorini.com/image/upload/v1717730187/Global/Investor/events/shareholders-meetings/2024/iss-reactive-statement_en.pdf)

*   [Partial Correction to the Notice of Convocation of the 148th Ordinary General Meeting of Shareholders](http://assets-dam.ducciofiorini.com/image/upload/v1717986546/Global/Investor/events/shareholders-meetings/2024/sm_148_05_en.pdf)

*   [Presentation](http://assets-dam.ducciofiorini.com/image/upload/v1719479941/Global/Investor/events/shareholders-meetings/2024/sm_148_07_en.pdf)

*   [Notice of Resolutions at the 148th Ordinary General Meeting of Shareholders](http://assets-dam.ducciofiorini.com/image/upload/v1718759459/Global/Investor/events/shareholders-meetings/2024/sm_148_06_en.pdf)

*   [Results of the Exercise of Voting Rights of the 148th Ordinary General Meeting of Shareholders](http://assets-dam.ducciofiorini.com/image/upload/v1719808017/Global/Investor/events/shareholders-meetings/2024/sm_148_08_en.pdf)

*   [The 148th Ordinary General Meeting of Shareholders (Video Recording)](http://bcove.video/3XNRk4n)

*   [The 148th Interim Period Report](http://jvgmtt.ducciofiorini.com/investors/events/interim-business-report/)

<div id="annual-shareholders-meetings">## Annual Shareholders Meetings</div>


*   [Notice of Convocation of the 147th Ordinary General Meeting of Shareholders](http://assets-dam.ducciofiorini.com/image/upload/v1687414710/Global/Investor/events/shareholders-meetings/2023/sm_147_01-2_en.pdf)

*   [Other items which are provided electronically](http://assets-dam.ducciofiorini.com/raw/upload/v1685345588/Global/Investor/events/shareholders-meetings/2023/sm_147_02_en.pdf)

*   [Message from Christophe Weber, President & CEO](http://assets-dam.ducciofiorini.com/raw/upload/v1685345588/Global/Investor/events/shareholders-meetings/2023/sm_147_03_en.pdf)

*   [Takeda’s executive compensation overview](http://assets-dam.ducciofiorini.com/raw/upload/v1685345588/Global/Investor/events/shareholders-meetings/2023/sm_147_04_en.pdf)

*   [FY2022 Q4 Financial Results](http://jvgmtt.ducciofiorini.com/investors/financial-results/quarterly-results/)

*   [Partial Correction to the Notice of Convocation of 147th Ordinary General Meeting of Shareholders](http://assets-dam.ducciofiorini.com/image/upload/v1687409671/Global/Investor/events/shareholders-meetings/2023/Notice_of_Amendment_to_be_posted_on_the_WEB.pdf)

*   [Presentation](http://assets-dam.ducciofiorini.com/image/upload/v1688013747/Global/Investor/events/shareholders-meetings/2023/sm_147_07_en.pdf)

*   [Notice of Resolutions](http://assets-dam.ducciofiorini.com/image/upload/v1687488561/Global/Investor/events/shareholders-meetings/2023/sm_147_06_en.pdf)

*   [Results of the Exercise of Voting Rights](http://assets-dam.ducciofiorini.com/image/upload/v1688114712/Global/Investor/events/shareholders-meetings/2023/sm_147_08_en.pdf)


147th Ordinary General Meeting of Shareholders(June 28, 2023)

*   [Business report (interim period)](http://assets-dam.ducciofiorini.com/image/upload/v1701060648/Global/Investor/events/shareholders-meetings/2023/br147_mid_en.pdf)



147th Interim Report

*   [Notice of convocation](http://assets-dam.ducciofiorini.com/raw/upload/v1662727586/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_01_en_1.pdf)

*   [Items disclosed via the Internet Concerning the Notice of Convocation of the Ordinary General Meeting of Shareholders](http://assets-dam.ducciofiorini.com/raw/upload/v1662727587/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_02_en.pdf)

*   [Message from Christophe Weber, President & CEO](http://assets-dam.ducciofiorini.com/raw/upload/v1662725889/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_03_en_1.pdf)

*   [Takeda's executive compensation overview](http://assets-dam.ducciofiorini.com/raw/upload/v1662727590/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_04_en.pdf)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1662727593/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_07_en.pdf)

*   [Notice of Resolutions](http://assets-dam.ducciofiorini.com/raw/upload/v1662727594/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_05_en.pdf)

*   [Results of the Exercise of Voting Rights](http://assets-dam.ducciofiorini.com/raw/upload/v1662727595/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_06_en.pdf)

146th Ordinary General Meeting of Shareholders(June 29, 2022)

*   [Business report (interim period)](http://assets-dam.ducciofiorini.com/raw/upload/v1669795726/legacy-dotcom/siteassets/system/investors/report/business/br146_mid_en.pdf)



146th Interim Report

*   [Notice of Convocation](http://assets-dam.ducciofiorini.com/raw/upload/v1662727596/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_01_en.pdf)

*   [Items Disclosed via the Internet Concerning the Notice of Convocation of the Ordinary General Meeting of Shareholders](http://assets-dam.ducciofiorini.com/raw/upload/v1662727597/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_02_en.pdf)

*   [Message from Christophe Weber, President & CEO](http://assets-dam.ducciofiorini.com/raw/upload/v1662727599/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_03_en.pdf)

*   [Takeda’s executive compensation overview](http://assets-dam.ducciofiorini.com/raw/upload/v1662727600/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_04_en_2.pdf)

*   [Partial Correction to the Notice of Convocation of the 145th Ordinary General Meeting of Shareholders](http://assets-dam.ducciofiorini.com/raw/upload/v1662727601/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_05_en.pdf)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1662727602/legacy-dotcom/siteassets/system/investors/shareholders-meetings/FY2021_GSM_28-June-2021_vF.pdf)

*   [Notice of Resolutions](http://assets-dam.ducciofiorini.com/raw/upload/v1662727603/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_06_en.pdf)

*   [Results of the Exercise of Voting Rights](http://assets-dam.ducciofiorini.com/raw/upload/v1662727604/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_07_en.pdf)

145th Ordinary General Meeting of Shareholders (June 29, 2021)

*   [Business report (interim period)](http://assets-dam.ducciofiorini.com/raw/upload/v1662727594/legacy-dotcom/siteassets/system/investors/report/business/br145_mid_en.pdf)



145th Interim Report

*   [Notice of Convocation](http://assets-dam.ducciofiorini.com/raw/upload/v1662727605/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_144_01_en.pdf)

*   [Items Disclosed via the Internet Concerning the Notice of Convocation of the Ordinary General Meeting of Shareholders](http://assets-dam.ducciofiorini.com/raw/upload/v1662727607/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_144_02_en.pdf)

*   [Message from Christophe Weber, President & CEO](http://assets-dam.ducciofiorini.com/raw/upload/v1662727608/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_144_03_en.pdf)

*   [Takeda's executive compensation overview](http://assets-dam.ducciofiorini.com/raw/upload/v1662727609/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_144_04_en.pdf)

*   [Partial Correction to the Items Disclosed via the Internet Concerning the Notice of Convocation of the 144th Ordinary General Meeting of Shareholders](http://jvgmtt.ducciofiorini.com/4ab49c/siteassets/system/investors/shareholders-meetings/e_notice-of-amendment-to-be-posted-on-the-web.pdf)

*   [144th Ordinary General Meeting of Shareholders Christophe Weber](http://assets-dam.ducciofiorini.com/raw/upload/v1675192637/legacy-dotcom/siteassets/system/investors/shareholders-meetings/cw2020_15min_gsm_presentation_1806.pdf)

*   [Notice of Resolutions](http://jvgmtt.ducciofiorini.com/4ab49c/siteassets/system/investors/shareholders-meetings/sm_144_05-en.pdf)

*   [Results of the Exercise of Voting Rights](http://jvgmtt.ducciofiorini.com/4ab49f/siteassets/system/investors/shareholders-meetings/sm_144_06_en.pdf)

144th Ordinary General Meeting of Shareholders (June 24, 2020)

*   [Business report (interim period)](http://assets-dam.ducciofiorini.com/raw/upload/v1662727596/legacy-dotcom/siteassets/system/investors/report/business/br144_mid_en.pdf)



144th Interim Report

*   [Notice of Convocation](http://assets-dam.ducciofiorini.com/raw/upload/v1662727611/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_01_en.pdf)

*   [Items Disclosed via the Internet Concerning the Notice of Convocation of the Ordinary General Meeting of Shareholders](http://assets-dam.ducciofiorini.com/raw/upload/v1662727612/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_02_en.pdf)

*   [Message from Christophe Weber, President & CEO](http://assets-dam.ducciofiorini.com/raw/upload/v1662727613/legacy-dotcom/siteassets/system/investors/shareholders-meetings/letter_1905_en.pdf)

*   [Partial Correction to the Notice of Convocation of the 143rd Ordinary General Meeting of Shareholders](http://assets-dam.ducciofiorini.com/raw/upload/v1662727613/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_03_en.pdf)

*   [Supplemental Material for the Proposals at the 143rd Ordinary General Meeting of Shareholders](http://assets-dam.ducciofiorini.com/raw/upload/v1662727614/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_04_en.pdf)

*   [Summary of Takeda’s Modifications to the Executive Compensation Program and Future Considerations](http://assets-dam.ducciofiorini.com/raw/upload/v1662727616/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_05_en.pdf)

*   [Takeda’s Recommendation to vote for Takeda’s Proposals at the 143rd Ordinary General Meeting of Shareholders](http://assets-dam.ducciofiorini.com/raw/upload/v1675192638/legacy-dotcom/siteassets/system/investors/shareholders-meetings/shareholder-engagement-response-e-final-clean-v3.pdf)

*   [A Statement of Confidence in the Leadership of Mr. Christophe Weber and Comments on the Proposals at the 143rd Ordinary General Meeting of Shareholders from Masahiro Sakane, the Chair of the Board of Directors Meeting of Takeda](http://assets-dam.ducciofiorini.com/raw/upload/v1675192638/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sakane-san-message_e-with-attachment.pdf)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1662727621/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_p01_en.pdf)

*   [Consolidated Financial Results for FY2018 and Guidance for FY2019](http://assets-dam.ducciofiorini.com/raw/upload/v1662727622/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_p02_en.pdf)

*   [Notice of Resolutions](http://assets-dam.ducciofiorini.com/raw/upload/v1675192644/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_06-en.pdf)

*   [Results of the Exercise of Voting Rights](http://assets-dam.ducciofiorini.com/raw/upload/v1662727623/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_07_en.pdf)

143rd Ordinary General Meeting of Shareholders (June 27, 2019)

*   [Business report (interim period)](http://assets-dam.ducciofiorini.com/raw/upload/v1662727597/legacy-dotcom/siteassets/system/investors/report/business/br143_mid_en.pdf)



143rd Interim Report

*   [Notice of Convocation](http://assets-dam.ducciofiorini.com/raw/upload/v1662727624/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_2018ext_01_en.pdf)

*   [Message from Christophe Weber, President & CEO, regarding the acquisition of Shire plc](http://assets-dam.ducciofiorini.com/raw/upload/v1662727625/legacy-dotcom/siteassets/system/investors/shareholders-meetings/letter_1811_en.pdf)

*   [Partial Correction to the Reference Document attached to the Notice of Convocation of the Extraordinary General Meeting of Shareholders](http://assets-dam.ducciofiorini.com/raw/upload/v1662727626/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_2018ext_1115_en.pdf)

*   [Presentation](http://assets-dam.ducciofiorini.com/raw/upload/v1662727628/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_2018ext_1210_01_en.pdf)

*   [Notice of Resolutions](http://assets-dam.ducciofiorini.com/raw/upload/v1662727629/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_2018ext_1205_en.pdf)

*   [Results of the Exercise of voting Rights](http://assets-dam.ducciofiorini.com/raw/upload/v1662727630/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_2018ext_1210_02_en.pdf)

*   [Learn more about the Shire offer](/investors/overview/offer-for-shire)



Extraordinary General Meeting of Shareholders (December 5, 2018)

## Past Shareholder Events & Reports



#### Online information session for retail investors: "Committed to Growth & Shareholder Returns" (in Japanese only)

7:45 pm - 8:30 pm JST on February 22, 2024

*   [Webcast](http://api01-platform.stream.co.jp/apiservice/plt3/NTk0NA%3d%3d%23NTI3Mg%3d%3d%23280%23168%23b%233FE2A0D9E400%23MDoyOjc6YTpmOzEwOzEwOzEw%23)
*   [Presentation](http://assets-dam.ducciofiorini.com/image/upload/v1710384814/Global/Investor/events/2024/presentation_02222024.pdf)

***

#### Information session for retail investors: "Better health for people, Brighter future for the world"

February 22, 2023

*   [Presentation](http://assets-dam.ducciofiorini.com/image/upload/v1678160771/legacy-dotcom/siteassets/system/investors/investor--events/20230222_retail%20investor%20event_presentation.pdf)

***

<div id="retail-investor-events">## Retail Investor Events</div>





Stay up to date on financial results, corporate milestones and learn how we're delivering on our commitment to patients, our people and the planet

## Sign up for our investors newsletter



The company’s most recent and important financial information

## Explore



Investor Events

Cancel

Links to sites outside of ducciofiorini.com are provided as a resource to the audiences. Please note that Takeda is not responsible or liable for any third-party website and the website may not be appropriate for all audiences. 

To stay on the current website, select “Cancel”
